Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD

OBJECTIVE: We performed a review of studies of fluticasone propionate (FP)/salmeterol (SAL) (combination inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA)) in patients with COPD, which measured baseline (pretreatment) blood eosinophil levels, to test whether blood eosinophil levels ≥2% were...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavord, Ian D, Lettis, Sally, Locantore, Nicholas, Pascoe, Steve, Jones, Paul W, Wedzicha, Jadwiga A, Barnes, Neil C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Chronic Obstructive Pulmonary Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752631/
https://www.ncbi.nlm.nih.gov/pubmed/26585525
http://dx.doi.org/10.1136/thoraxjnl-2015-207021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752631/
https://www.ncbi.nlm.nih.gov/pubmed/26585525
http://dx.doi.org/10.1136/thoraxjnl-2015-207021

Ejemplares similares